Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Jun;52(6):450–454. doi: 10.1136/jcp.52.6.450

Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.

G A Meijer 1, A B Schroeijers 1, M J Flens 1, S G Meuwissen 1, P van der Valk 1, J P Baak 1, R J Scheper 1
PMCID: PMC501433  PMID: 10562814

Abstract

AIM: To analyse the expression of multidrug resistance (MDR) related proteins at different steps in colorectal carcinogenesis. METHODS: The presence of three MDR related proteins (Pgp, MRP1, and LRP/MVP) was studied by means of immunohistochemistry in normal, adenomatous, and malignant colorectal epithelium. Formaldehyde fixed, paraffin embedded tissue sections of 17 samples of colorectal tissue were used (normal mucosa, n = 4; adjacent mucosa, n = 5; adenoma, n = 5; carcinoma, n = 3). RESULTS: For all three proteins, expression was found in the surface epithelium and the upper parts of the crypts in normal colon. In the adenomas, staining was seen along the complete length of the crypts. In the carcinomas analysed, all epithelium showed positive staining. Mucosa adjacent to either carcinoma or adenoma showed staining patterns mostly resembling those of normal mucosa, but sometimes some extension of staining was seen along the crypt. CONCLUSIONS: These proteins already show increased expression in the adenoma stage. In the absence of adequate mucin production in adenomas, MDR related proteins could be an important factor in protecting the epithelium against further environmentally induced genetic damage. This could be one of the reasons why only about 5% of colorectal adenomas will actually progress to carcinomas.

Full text

PDF
450

Images in this article

452Image
on p.452
453Image
on p.453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arceci R. J., Stieglitz K., Bras J., Schinkel A., Baas F., Croop J. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res. 1993 Jan 15;53(2):310–317. [PubMed] [Google Scholar]
  2. Biedler J. L. Genetic aspects of multidrug resistance. Cancer. 1992 Sep 15;70(6 Suppl):1799–1809. doi: 10.1002/1097-0142(19920915)70:4+<1799::aid-cncr2820701623>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  3. Cole S. P., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., Stewart A. J., Kurz E. U., Duncan A. M., Deeley R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992 Dec 4;258(5088):1650–1654. doi: 10.1126/science.1360704. [DOI] [PubMed] [Google Scholar]
  4. Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R., Bertino J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989 Jan;86(2):695–698. doi: 10.1073/pnas.86.2.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Endicott J. A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 1989;58:137–171. doi: 10.1146/annurev.bi.58.070189.001033. [DOI] [PubMed] [Google Scholar]
  6. Flens M. J., Izquierdo M. A., Scheffer G. L., Fritz J. M., Meijer C. J., Scheper R. J., Zaman G. J. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 1994 Sep 1;54(17):4557–4563. [PubMed] [Google Scholar]
  7. Flens M. J., Zaman G. J., van der Valk P., Izquierdo M. A., Schroeijers A. B., Scheffer G. L., van der Groep P., de Haas M., Meijer C. J., Scheper R. J. Tissue distribution of the multidrug resistance protein. Am J Pathol. 1996 Apr;148(4):1237–1247. [PMC free article] [PubMed] [Google Scholar]
  8. Gottesman M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385–427. doi: 10.1146/annurev.bi.62.070193.002125. [DOI] [PubMed] [Google Scholar]
  9. Hatch F. T., Knize M. G., Healy S. K., Slezak T., Felton J. S. Cooked-Food Mutagen Reference List and Index. Environ Mol Mutagen. 1988;12 (Suppl 14):1–85. doi: 10.1002/em.2860120602. [DOI] [PubMed] [Google Scholar]
  10. Herbergs J., de Bruïne A. P., Marx P. T., Vallinga M. I., Stockbrügger R. W., Ramaekers F. C., Arends J. W., Hopman A. H. Chromosome aberrations in adenomas of the colon. Proof of trisomy 7 in tumor cells by combined interphase cytogenetics and immunocytochemistry. Int J Cancer. 1994 Jun 15;57(6):781–785. doi: 10.1002/ijc.2910570604. [DOI] [PubMed] [Google Scholar]
  11. Higgins C. F. ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67–113. doi: 10.1146/annurev.cb.08.110192.000435. [DOI] [PubMed] [Google Scholar]
  12. Izquierdo M. A., Scheffer G. L., Flens M. J., Giaccone G., Broxterman H. J., Meijer C. J., van der Valk P., Scheper R. J. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol. 1996 Mar;148(3):877–887. [PMC free article] [PubMed] [Google Scholar]
  13. Jedlitschky G., Leier I., Buchholz U., Center M., Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 1994 Sep 15;54(18):4833–4836. [PubMed] [Google Scholar]
  14. Kedersha N. L., Miquel M. C., Bittner D., Rome L. H. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol. 1990 Apr;110(4):895–901. doi: 10.1083/jcb.110.4.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kickhoefer V. A., Rajavel K. S., Scheffer G. L., Dalton W. S., Scheper R. J., Rome L. H. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem. 1998 Apr 10;273(15):8971–8974. doi: 10.1074/jbc.273.15.8971. [DOI] [PubMed] [Google Scholar]
  16. Konishi F., Morson B. C. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol. 1982 Aug;35(8):830–841. doi: 10.1136/jcp.35.8.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kool M., de Haas M., Scheffer G. L., Scheper R. J., van Eijk M. J., Juijn J. A., Baas F., Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997 Aug 15;57(16):3537–3547. [PubMed] [Google Scholar]
  18. Loe D. W., Almquist K. C., Deeley R. G., Cole S. P. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J Biol Chem. 1996 Apr 19;271(16):9675–9682. doi: 10.1074/jbc.271.16.9675. [DOI] [PubMed] [Google Scholar]
  19. Meijer G. A., Hermsen M. A., Baak J. P., van Diest P. J., Meuwissen S. G., Beliën J. A., Hoovers J. M., Joenje H., Snijders P. J., Walboomers J. M. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol. 1998 Dec;51(12):901–909. doi: 10.1136/jcp.51.12.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nagengast F. M., Grubben M. J., van Munster I. P. Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1067–1070. doi: 10.1016/0959-8049(95)00216-6. [DOI] [PubMed] [Google Scholar]
  21. Nooter K., Bosman F. T., Burger H., van Wingerden K. E., Flens M. J., Scheper R. J., Oostrum R. G., Boersma A. W., van der Gaast A., Stoter G. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol. 1996 Jan;7(1):75–81. doi: 10.1093/oxfordjournals.annonc.a010484. [DOI] [PubMed] [Google Scholar]
  22. Paulusma C. C., Bosma P. J., Zaman G. J., Bakker C. T., Otter M., Scheffer G. L., Scheper R. J., Borst P., Oude Elferink R. P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science. 1996 Feb 23;271(5252):1126–1128. doi: 10.1126/science.271.5252.1126. [DOI] [PubMed] [Google Scholar]
  23. Potter J. D. Colon cancer--do the nutritional epidemiology, the gut physiology and the molecular biology tell the same story? J Nutr. 1993 Feb;123(2 Suppl):418–423. doi: 10.1093/jn/123.suppl_2.418. [DOI] [PubMed] [Google Scholar]
  24. Riddell R. H. The adenoma-carcinoma sequence. Prog Clin Biol Res. 1988;279:23–33. [PubMed] [Google Scholar]
  25. Rome L., Kedersha N., Chugani D. Unlocking vaults: organelles in search of a function. Trends Cell Biol. 1991 Aug;1(2-3):47–50. doi: 10.1016/0962-8924(91)90088-q. [DOI] [PubMed] [Google Scholar]
  26. Scheffer G. L., Wijngaard P. L., Flens M. J., Izquierdo M. A., Slovak M. L., Pinedo H. M., Meijer C. J., Clevers H. C., Scheper R. J. The drug resistance-related protein LRP is the human major vault protein. Nat Med. 1995 Jun;1(6):578–582. doi: 10.1038/nm0695-578. [DOI] [PubMed] [Google Scholar]
  27. Scheper R. J., Broxterman H. J., Scheffer G. L., Kaaijk P., Dalton W. S., van Heijningen T. H., van Kalken C. K., Slovak M. L., de Vries E. G., van der Valk P. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 1993 Apr 1;53(7):1475–1479. [PubMed] [Google Scholar]
  28. Scheper R. J., Bulte J. W., Brakkee J. G., Quak J. J., van der Schoot E., Balm A. J., Meijer C. J., Broxterman H. J., Kuiper C. M., Lankelma J. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int J Cancer. 1988 Sep 15;42(3):389–394. doi: 10.1002/ijc.2910420314. [DOI] [PubMed] [Google Scholar]
  29. Schroeijers A. B., Scheffer G. L., Flens M. J., Meijer G. A., Izquierdo M. A., van der Valk P., Scheper R. J. Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues. Am J Pathol. 1998 Feb;152(2):373–378. [PMC free article] [PubMed] [Google Scholar]
  30. Slovak M. L., Ho J. P., Cole S. P., Deeley R. G., Greenberger L., de Vries E. G., Broxterman H. J., Scheffer G. L., Scheper R. J. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res. 1995 Oct 1;55(19):4214–4219. [PubMed] [Google Scholar]
  31. Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7735–7738. doi: 10.1073/pnas.84.21.7735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Van Tassell R. L., Kingston D. G., Wilkins T. D. Metabolism of dietary genotoxins by the human colonic microflora; the fecapentaenes and heterocyclic amines. Mutat Res. 1990 May;238(3):209–221. doi: 10.1016/0165-1110(90)90013-2. [DOI] [PubMed] [Google Scholar]
  33. Vargas P. A., Alberts D. S. Primary prevention of colorectal cancer through dietary modification. Cancer. 1992 Sep 1;70(5 Suppl):1229–1235. doi: 10.1002/1097-0142(19920901)70:3+<1229::aid-cncr2820701507>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  34. Zaman G. J., Flens M. J., van Leusden M. R., de Haas M., Mülder H. S., Lankelma J., Pinedo H. M., Scheper R. J., Baas F., Broxterman H. J. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8822–8826. doi: 10.1073/pnas.91.19.8822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. van der Valk P., van Kalken C. K., Ketelaars H., Broxterman H. J., Scheffer G., Kuiper C. M., Tsuruo T., Lankelma J., Meijer C. J., Pinedo H. M. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Ann Oncol. 1990;1(1):56–64. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES